Bachem raises $116 million through capital increase
Company will invest in capacity increases, technological capabilities and long-term partnerships with key pharmaceutical and biotech companies
Company will invest in capacity increases, technological capabilities and long-term partnerships with key pharmaceutical and biotech companies
New GMP facility for clinical and small-scale commercial pharmaceutical lipids
The common stock of Concert will no longer be listed for trading on the Nasdaq Global Market
She was the CEO of Tata Insights and Quants a Division of the Tata Industries Ltd.
Jan Aushadhi highlights achievements of women of the country at 34 locations by felicitating all women stakeholders under the scheme
Dr. Adams brings more than two decades of experience leading the manufacturing of biologic and gene therapies at all stages of development.
This action follows the recent acceptance of the Marketing Authorization Application (MAA) for Pfizer’s RSV vaccine candidate by the European Medicines Agency
First release of Rs.166 crores incentives under PLI scheme for pharmaceuticals
The new company will utilize Teijin's drug discovery research technologies, facilities, equipment and personnel.
Astellas stands on the forefront of healthcare change to turn innovative science into value for patients
Subscribe To Our Newsletter & Stay Updated